Piramal Pharma Q3 FY25 Results
Piramal Pharma has released its financial results for the Q3 quarter of Financial Year 24-2025. Here's a comprehensive breakdown of the company's performance:
Revenue Analysis
- Current Quarter Revenue: Rs. 2,204.22 Cr
- Quarter-on-Quarter (QoQ) Change: -1.67% (Previous Quarter: Rs. 2,241.75 Cr )
- Year-on-Year (YoY) Change: 12.54% (Same Quarter Last Year: Rs. 1,958.57 Cr )
Profitability Metrics
- Net Profit: Rs. 3.68 Cr
- QoQ Profit Change: -83.71% (Previous Quarter: Rs. 22.59 Cr )
- YoY Profit Change: -63.60% (Same Quarter Last Year: Rs. 10.11 Cr )
Shareholder Returns
- Earnings Per Share (EPS): Rs. 0.03
- QoQ EPS Change: -82.35% (Previous Quarter: Rs. 0.17)
- YoY EPS Change: -62.50% (Same Quarter Last Year: Rs. 0.08)
Performance Summary
Mixed
Piramal Pharma had a complex financial situation. Different parts of the business are performing differently, showing a changing market.
This analysis provides a snapshot of Piramal Pharma's financial performance. Investors and analysts should consider these results in the context of broader market trends and the company's long-term strategy.
Disclaimer:
This information is for informational purposes only. Please reverify all details from official sources before making any financial decisions. The accuracy and completeness of this data cannot be guaranteed.